Alzheimer Disease: all 3,765 studies
Page 38 of 38. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.
- Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)CompletedNCT00074529Phase 2
- A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's DiseaseTerminatedNCT00069849Phase 2
- Alzheimer's Disease: Therapeutic Potential of EstrogenCompletedNCT00066157Phase 2/3
- Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's DiseaseCompletedNCT00065767Phase 2/3
- High Intensity Light Therapy in Alzheimer's DiseaseCompletedNCT00065689Phase 3
- Delaying Alzheimer Disease Symptoms With Anti-Inflammatory DrugsCompletedNCT00065169Not applicable
- ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigationCompletedNCT00063310Phase 2
- Bathing Persons With Alzheimer's Disease aT Home (The BATH Study)CompletedNCT00062569Not applicable
- Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) IICompletedNCT00059410
- COGNIShunt® System for Alzheimer's DiseaseCompletedNCT00056628Phase 3
- Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)CompletedNCT00056524Phase 3
- Vitamin E in Aging Persons With Down SyndromeStatus unknownNCT00056329Phase 3
- VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)CompletedNCT00056225Phase 3
- Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease StudyCompletedNCT00053599Phase 3
- Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's DiseaseCompletedNCT00051909Phase 2
- The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's DiseaseCompletedNCT00046358Phase 4
- Treatment for Early Memory LossCompletedNCT00042172Phase 4
- Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's TypeCompletedNCT00041678Phase 3
- Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)CompletedNCT00040378
- Brain Imaging in Alzheimer's DiseaseCompletedNCT00039702
- Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's TypeCompletedNCT00036114Phase 3
- A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's DiseaseCompletedNCT00035204Phase 4
- Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's DiseaseCompletedNCT00034762Phase 3
- Healthy Aging and Memory StudyCompletedNCT00034567
- Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon AlphaStatus unknownNCT00031018Phase 2
- Evaluation of Age- and Alzheimer's Disease-Related Memory DisorderCompletedNCT00029120
- Lipitor as a Treatment for Alzheimer's DiseaseCompletedNCT00024531Phase 2
- Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's DiseaseTerminatedNCT00021723Phase 2
- Gene-Environment Interactions in Alzheimer's DiseaseCompletedNCT00018473
- Insulin, Neurogenetics and Memory in Alzheimer's DiseaseCompletedNCT00018382Phase 2
- Alzheimer's Disease and Aging: Therapeutic Potential of EstrogenCompletedNCT00018343Phase 2
- Specific Interventions for Agitation in Alzheimer's DiseaseCompletedNCT00018291Not applicable
- Electrophysiologic Measures of Treatment Response in Alzheimer DiseaseCompletedNCT00018278Phase 4
- Gene Therapy for Alzheimer's Disease Clinical TrialCompletedNCT00017940Phase 1
- CATIE-Alzheimer's Disease TrialCompletedNCT00015548Not applicable
- Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer DiseaseCompletedNCT00013923Phase 2
- Effects of an Anti-Inflammatory Drug in Alzheimer's DiseaseCompletedNCT00013650Phase 1
- Effect of Activity on Sleep of Cognitively-Impaired VeteransCompletedNCT00013182Not applicable
- Pain Management and Behavioral Outcomes in Patients With DementiaCompletedNCT00012857Phase 2
- Nurse Managed Clinic for Dementia Patients and Family CaregiversCompletedNCT00012831
- Treatment of Behavioral Symptoms in Alzheimer's DiseaseCompletedNCT00009217Phase 4
- Serotonergic Pharmacotherapy for Agitation of DementiaCompletedNCT00009204Phase 3
- The Depression in Alzheimer's Disease Study (DIADS)CompletedNCT00009191Phase 4
- Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)CompletedNCT00007189Phase 3
- Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's DiseaseCompletedNCT00006399Phase 2
- The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's DiseaseTerminatedNCT00006187Phase 3
- Clinical and Genetic Studies of Familial Presenile Dementia With Neuronal Inclusion BodiesCompletedNCT00006176
- A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)CompletedNCT00004845Phase 2/3
- The Effect of Acetylcholine on Memory and AttentionCompletedNCT00001977
- PET Scan of Brain Metabolism in Relation to Age and DiseaseCompletedNCT00001972
- Nefiracetam in the Treatment of Alzheimer's DiseaseCompletedNCT00001933Phase 2
- Brain Imaging in Elderly People and Individuals With Alzheimer's DiseaseCompletedNCT00001917
- Treatment of Alzheimer's Disease With CX516 (Ampalex)CompletedNCT00001662Phase 2
- Diagnosis and Natural History Study of Patients With Neurological ConditionsCompletedNCT00001549
- The Evaluation and Follow-up of Individuals With Memory DisorderCompletedNCT00001480
- Genetic Studies in Alzheimer's DiseaseCompletedNCT00001235
- Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian DisordersTerminatedNCT00001178
- Agitation in Alzheimer's DiseaseCompletedNCT00000179Phase 3
- Multicenter Trial of Prednisone in Alzheimer's DiseaseCompletedNCT00000178Phase 3
- Estrogen Hormone ProtocolCompletedNCT00000177Phase 3
- Alzheimer's Disease Prevention TrialCompletedNCT00000176Phase 3
- Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)CompletedNCT00000174Phase 3
- Memory Impairment Study (Mild Cognitive Impairment Study)CompletedNCT00000173Phase 3
- Evaluation of Galantamine in the Treatment of Alzheimer's DiseaseCompletedNCT00000172Phase 3
- Study of Melatonin: Sleep Problems in Alzheimer's DiseaseCompletedNCT00000171Phase 3